Apoptotic cell clearance in systemic lupus erythematosus: II. Role of β2-glycoprotein I

Arthritis and Rheumatism

Volumn 41, Issue 2, 1998, Pages 215-223

  Manfredi, Angelo A ^a,c   Rovere, Patrizia ^a   Heltai, Silvia ^a   Galati, Giacomo ^a   Nebbia, Gaia ^a   Tincani, Angela ^b   Balestrieri, Genesio ^b   Sabbadini, Maria Grazia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Servizio di Immunologia Clinica   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; FAS ANTIGEN; PHOSPHOLIPID ANTIBODY;

ANTIGEN RECOGNITION; ANTIPHOSPHOLIPID SYNDROME; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKEMIA CELL LINE; OPSONIZATION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTIPHOSPHOLIPID; APOPTOSIS; BETA 2-GLYCOPROTEIN I; GLYCOPROTEINS; HUMANS; JURKAT CELLS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGES; OPSONIN PROTEINS; PHOSPHATIDYLSERINES;

EID: 0031887591     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199802)41:2<215::AID-ART5>3.0.CO;2-X     Document Type: Article

References (56)

1. Platt N, Suzuki H, Kurihara J, Kodama I, Gordon S. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc Natl Acad Sci U S A 1996;93: 12456-60.
2. Stern M, Savill J, Haslett C. Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Am J Pathol 1996;149:911-21.
3. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993;14:131-6.
4. Henson PM, Johnston RB. Tissue injury in inflammation: oxidants proteinases and cationic proteins. J Clin Invest 1987;79:669-88.
5. Fadok VA, Savill J, Haslett C, Bratton DL, Doherty DE, Campbell PA, et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992;149:4029-35.
6. Mosher DF. Physiology of thrombospondin. Annu Rev Med 1990;41:85-114.
7. 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992;1:75-82.
8. Galli M, Comfurius P, Maassen C, Hemker HC, De-Baets MH, van-Breda-Vriesman PJ, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-7.
9. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 1990;87:4120-4.
10. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T, et al. Heterogeneity of anticardiolipin antibodies defined by the anti-cardiolipin cofactor. J Immunol 1992;148: 3885-91.
11. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994;179:457-62.
12. 2-glycoprotein I. Thromb Haemost 1992;67:499-511.
13. 2-glycoprotein I. J Clin Invest 1992;90:1100-4.
14. 2-glycoprotein I critical for lipid binding and cardiolipin antibody cofactor activity. Proc Natl Acad Sci U S A 1993;90:2141-5.
15. 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. J Immunol 1994;152:653-9.
16. Wang MX, Kandiah DA, Ichikawa K, Khamashta M, Hughes G, Koike T, et al. Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome. J Immunol 1995;155:1629-36.
17. Sheng YH, Sali A, Herzog H, Lahnstein J, Krilis SA. Site-directed mutagenesis of recombinant human beta2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipids binding and anti-cardiolipin antibody activity. J Immunol 1996; 157:3744-51.
18. 2-GPI dependent fashion [abstract]. Lupus 1996;5:558.
19. Manfredi AA, Rovere P, Galati G, Heltai S, Bozzolo E, Soldini L, et al. Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies. Arthritis Rheum 1998;41:205-14.
20. 2-glycoprotein I induces charge-dependent cross-reactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies. J Immunol 1995;155:958-66.
21. Gharavi AE, Sammaritano LR, Bovastro JL, Wilson WA. Specificity and characteristics of beta 2 glycoprotein I-induced antiphospholipid antibodies. J Lab Clin Med 1995;125:775-8.
22. Garcia CO, Kanbourshakir A, Tang H, Molina JF, Espinoza LR, Gharavi AE. Induction of experimental antiphospholipid syndrome in PL/J mice following immunization with beta 2 GPI. Am J Reprod Immunol 1997;37:118-24.
23. 2-glycoprotein I in the absence of phospholipid: importance of Ag density and bivalent binding. J Immunol 1995;154:954-60.
24. Willems GM, Janssen MP, Pelsers MAL, Cumfurius P, Galli M, Zwaal RFA, et al. Role of divalency in the high affinity binding of anticardiolipin antibody-beta2-glycoprotein I complexes to antiphospholipid membranes. Biochemistry 1996;35:13833-42.
25. 2-glycoprotein I-dependent manner. J Immunol 1996;157:2201-8.
26. Ferrarini M, Heltai S, Toninelli E, Sabbadini MG, Pellicciari C, Manfredi AA. Daudi lymphoma killing triggers the programmed death of cytotoxic Vγ9/Vδ2 T lymphocytes. J Immunol 1995;154: 3704-12.
27. Rovere P, Clementi E, Ferrarini M, Heltai S, Sciorati C, Sabbadini MG, et al. CD95 engagement releases calcium from intracellular stores of long term activated, apoptosis-prone γδ T cells. J Immunol 1996;156:4631-7.
28. Pellicciari C, Bottone MG, Schaak V, Manfredi AA, Barni S. Etoposide at different concentrations may open different apoptotic pathways in thymocytes. Eur J Histochem 1996;40:289-98.
29. Winzler C, Rovere P, Rescigno M, Granucci F, Penna G, Adorini L, et al. Maturation stages of mouse dendritic cells in growth-factor-dependent long-term cultures. J Exp Med 1997;185:317-28.
30. 2-glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J Rheumatol 1994;21:1684-93.
31. Polz E, Wurm H, Kostner GM. Investigation on beta 2-glycoprotein I in the rat: isolation from serum and demonstration in lipoprotein density fraction. J Biochem 1980;11:265-70.
32. 2 glycoprotein I and the influence of plasma lipids. Thromb Res 1993;72: 275-86.
33. Balestrieri G, Tincani A, Spatola L, Allegri F, Prati E, Cattaneo R, et al. Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus 1995;4:122-30.
34. Harris EN. The second international anti-cardiolipin standardization workshop/the Kingston anti-phospholipid antibody study (KAPS). Am J Clin Pathol 1990;94:476-84.
35. Pellicciari C, Manfredi AA, Bottone MG, Schaak V, Barni S. A single step staining procedure for the detection and sorting of unfixed apoptotic thymocytes. Eur J Histochem 1993;37:381-90.
36. Casciola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced pro-coagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A 1996;93:1624-9.
37. 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 1996;39:1466-74.
38. Tincani A, Spatola L, Prati E, Allegri F, Ferremi P, Cattaneo R, et al. The anti-beta 2 glycoprotein I activity in human antiphospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta 2 glycoprotein I and preserved during species evolution. J Immunol 1996;157:5732-8.
39. Shapiro SS. The lupus anticoagulant/antiphospholipid syndrome. Annu Rev Med 1996;47:533-53.
40. Roubey RAS. Antibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" antibodies. Blood 1994;84:2854-67.
41. Roubey RAS. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum 1996;39:1444-54.
42. Harris EN, Pierangeli SS. Antiphospholipid antibodies and the antiphospholipid syndrome. Springer Semin Immunopathol 1994; 16:223-45.
43. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991;49: 193-280.
44. Sammaritano LR, Gharavi AE, Lockshin MD. Antiphospholipid antibody: immunologic and clinical aspects. Semin Arthritis Rheum 1990;20:81-96.
45. Stuart MC, Bevers EM, Comfurius P, Zwaal RF, Reutelingsperger CP, Frederik PM. Ultrastructural detection of surface exposed phosphatidylserine on activated blood platelets. Thromb Haemost 1995;74:1145-51.
46. Santoro SA. Antiphospholipid antibodies and thrombotic predisposition: underlying pathogenetic mechanisms. Blood 1994;83: 2389-91.
47. Fadok VA, Voelker DR, Kampbel PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992;148:2207-16.
48. Kerr JFR, Willie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-range implications in tissue kinetics. Br J Cancer 1972;26:239-57.
49. Raff MC. Social controls on cell survival and cell death. Nature 1992;356:397-400.
50. Steller SJ. Mechanisms and genes of cellular suicide. Science 1995;267:1445-9.
51. Bellamy CO, Malcomson RD, Harrison DJ, Wyllie AH. Cell death in health and disease: the biology and regulation of apoptosis. Semin Cancer Biol 1995;6:3-16.
52. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance. Ann Intern Med 1990;112:682-98.
53. Pierangeli SS, Harris EN. Induction of phospholipid antibodies in mice and rabbits by immunization with human beta 2 glycoprotein 1 or anticardiolipin antibodies alone. Clin Exp Immunol 1993;85: 269-72.
54. Aron AL, Cuellar ML, Brey RL, Mckeown S, Espinoza LR, Shoenfield Y, et al. Early onset of autoimmunity in MRL+/+ mice following immunization with beta 2 glycoprotein I. Clin Exp Immunol 1995;101:78-81.
55. Simantov R, LaSala JM, Lo SK, Gharavi AG, Sammaritano LR, Salmon JE, et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995;96:2211-9.
56. 2-glycoprotein I and induce endothelial activation. Arthritis Rheum 1997;40:551-61.